title: Reflections on the changing face of German pharmaceutical policy: how far is Germany from value-based pricing?
authors.affiliation: Institute for Quality and Efficiency in Health Care, Cologne, Germany. andreas.gerber@iqwig.de
authors.forename: Andreas
authors.initials: A
authors.lastname: Gerber
authors.forename: Stephanie
authors.initials: S
authors.lastname: Stock
authors.forename: Charalabos-Markos
authors.initials: CM
authors.lastname: Dintsios
mesh_terms: D016527:Drug Costs / Q000639:trends*; D005858:Germany; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics / Q000639:trends; D004364:Pharmaceutical Preparations / Q000191:economics*; D011907:Rate Setting and Review / Q000379:methods* / Q000639:trends; D012051:Reimbursement Mechanisms / Q000191:economics / Q000639:trends
chemical_list: D004364:Pharmaceutical Preparations